Emergent Biosolutions IncAdd to My Watchlist

EBS:USNew YorkIndustry: Medical-Biomedical/Gene
  • 28.62
    Last
  • 0.16  -0.56%
    Today's Change
  • 28.78
    Previous Close
  • Today
     
    19.31
    29.00
    52 Week Low - High
1:14 pm ET 1/29/2015
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding38 million
Market Cap$1 billion
Return on Equity ttm4.46%
Last DividendEBS:US does not pay a dividend
Earnings
EPS: Year Actual ttm0.710
EPS: Year Est. 12/14 ttm0.985
 
EPS: Quarterly Actual 9/14 0.50
EPS: Quarterly Est. 12/14 0.64
 
Price/Earnings ttm40.30
Relative Price/Earnings2.279
Earnings Growth Rate32.31
Company Description
Emergent Biosolutions, Inc. develops and produces immunobiotics, pharmaceutical products that assist the body's immune system to prevent or treat disease. The Company produces a vaccine for anthrax.
Revenue$313 million
Net Income$31 million
Total Assets$627 million
Employees1,353
Web Sitewww.emergentbiosolutions.com

Latest Headlines

Watchlist

Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

Sign In Now

 

Not Registered?

Get complete access to The Washington Post online - it's FREE!